To study the effects of the intake of green tea and polyphenols, which are a component of green tea, on insulin resistance and systemic inflammation, a randomized controlled trial was conducted on 66 patients aged 32-73y (53 males and 13 females) with borderline diabetes or diabetes. Subjects in the intervention group were asked to take a packet of green tea extracts/powder containing 544mg polyphenols (456mg catechins) daily, which was a dose that could be taken without difficulty, and were asked to divide the green tea extracts/powder in a packet into 3 or 4 fractions dissolved in hot water everyday and to take a fraction after every meal or snack for 2mo, in addition to daily food intake. The subjects in the control group were simply followed. To calculate the level of green tea polyphenol intake that the subject usually drank at home, the subject was asked to taste 3 teas of different strengths (1, 2 and 3%) and the tea that was closest to the one that the sub ject drank at home, was selected by each subject. After 2 mo, the mean daily polyphenol intake in the intervention group was 747mg, which was significantly higher than that of 469mg in the control group. In the intervention group, the body weight, BMI, systolic and diastolic blood pressures, blood glucose level, Hb A1c level, insulin level and HOMA index after taking the supplementation for 2mo, were lower than the respective value before inter vention; however, these parameters in the intervention group at 2mo did not significantly differ from those in the control group. Within the intervention group, changes in insulin level tended to be associated with changes in polyphenol intake. In addition, changes in BMI were associated with changes in blood glucose level and insulin level. In conclusion, the daily supplementary intake of 500mg green tea polyphenols did not have clear effects on blood glucose level, Hb Ale level, insulin resistance or inflammation markers. The positive correlation between the level of polyphenol intake and insulin level warrants further studies on the effect of green tea on insulin resistance.
Green tea contains a variety of compounds including polyphenols, caffeine, vitamin C and carotene. To date, there have been reports on the physiological effects of green tea including its anti-cancer properties (1-7), anti-oxidant properties (8, 9) , and anti-bacterial prop erties (10) (11) (12) . Green tea has been reported to reduce the serum cholesterol level (13, 14) , body weight, body mass index (BMI), body fat (15) (16) (17) , and blood glucose level (18) , and green tea is expected to show preventive effects on the development of life style-related diseases. However, nutritional and epidemiological studies on the health effects of green tea consumption in humans are scarce, and it is not clear whether green tea can prevent the development of diabetes and cardiovascular diseases.
E-mail: fukino@u-shizuoka-ken.ac.jp Among the polyphenols (catechins) in green tea, epi catechin gallate (ECG) and epigalocatechin gallate (EGCG) strongly inhibit the activity of saccharolytic enzymes, i.e., a-amylase and sucrose. It has been sug gested that drinking green tea interferes with the absorption of sugars from the alimentary tract, thus attenuating high blood glucose level (18) (19) (20) . Further more, the polyphenols in green tea have anti-oxidant activity towards low-density lipoprotein (LDL)-choles terol (21, 22) .
In our previous cross-sectional studies, we found that green tea consumption was negatively associated with serum lipids, liver dysfunction, and the blood glucose level (23, 24) . In addition, our preliminary uncon trolled trial on borderline diabetic patients suggested that green tea consumption reduces the blood glucose and hemoglobin (Hb) Ale levels, as well as blood pres sure, total cholesterol level and body fat (25) . These studies suggest that green tea may be effective in pre venting the development of not only diabetes but also cardiovascular diseases.
The level of high-sensitivity C-reactive protein (hs CRP) has been recognized as a sensitive biomarker of inflammation and a risk factor for diabetes and cardio vascular diseases (26, 27) . Therefore, investigation of the effect of consumption of green tea and its constitu ent polyphenols on blood glucose, insulin level and insulin resessstance and hs-CRP level is expected to pro vide important clues in the prevention of diabetes and cardiovascular diseases.
A recent population-based study indicated an increase in the prevalence of diabetes (28) , as well as that for borderline type diabetes or glucose intolerance among Japanese (29) . Thus, it is desirable to investigate the effect of green tea consumption on insulin resis tance and inflammation markers in diabetic patients and borderline diabetic patients, but such studies have been scarce. In this study, we analyzed the effects of green tea consumption on the blood glucose level, insu lin level, insulin resistance as evaluated by the HOMA index (30) , hemoglobin Al level, and hs-CRP level in a randomized controlled trial of men and women with diabetes or borderline diabetes. Supplementation of green tea was performed using green tea extract pow der that contained 544mg of polyphenols.
PATIENTS AND METHODS
Patients, method of study and term of study. We deter mined the period of intervention as 2 mo because previ ous studies showed that 1-mo supplementation of 400mg/d green tea polyphenol induced a significant reduction of methylguanidine, a marker of biological antioxidant (31) , and that supplementation of 588mg/ d catechins induced a significant weight reduction (15) after 1 and 3 mo.
The subjects were residents of communities on the eastern side of Shizuoka Prefecture, Japan, who had a fasting blood glucose level of 110mg/dL or a non fasting blood glucose level 140mg/dL in recent health check-ups of communities and companies. We asked them to participate in the study and obtained informed consent from 56 males and 14 females aged 32-73y. Excluding those individuals who dropped out of the study and those who had eaten breakfast on the morning of baseline data sampling, the subjects con sisted of 53 males and 13 females. This study was approved by the Research Ethics Committee of Univer sity of Shizuoka.
The baseline sampling was performed in late Febru ary to early March 2003. The subjects were asked not to eat breakfast on the morning of the baseline data sampling. The subjects were randomly divided into the intervention group who received the supplementation of green tea extract/powder, or the control group who did not receive the supplementation. Table 1 shows the baseline characteristics of the intervention and control groups. The ratio of males to females was 4:1 in both groups. There were no signifi cant differences in age or other baseline characteristics between the two groups. Table 2 summarizes the data on polyphenol intake and data from the physical and laboratory examina tions in the intervention group after 2 mo of interven tion and the control group. The level of polyphenol intake was 747mg/d in the intervention group and 469mg/d in the control group, showing a significant difference. However, the body weight, BMI, systolic and diastolic blood pressures, blood glucose level, Hb Ale level, HOMA index and insulin level in the intervention group at 2 mo did not significantly differ from the respective parameter in the control group. The hs-CRP level tended to be higher in the intervention group at 2 mo than in the control group (p=0.06). Figures 1-6 show graphs of the change in polyphenol intake versus the changes in the insulin level (Fig. 1) , blood glucose level (Fig. 2), HOMA index (Fig. 3) , Hb Ale level (Fig. 4) , hs-CRP level (Fig. 5) and BMI (Fig. 6 ) in June 2003, among the subjects in the intervention Fig. 1 . The relationship between the changes in polyphenol intake and the changes in fasting serum insulin levels among the subjects in the intervention group. Fig. 2 . The relationship between the changes in polyphenol intake and the changes in fasting serum glucose levels among the subjects in the intervention group. Fig. 3 . The relationship between the changes in polyphenol intake and the changes in HOMA index among the subjects in the intervention group. Fig. 4 . The relationship between the changes in polyphenol intake and the changes in fasting serum hemoglobin Ale among the subjects in the intervention group. Fig. 5 . The relationship between the changes in polyphenol intake and the changes in fasting serum C-reactive protein among the subjects in the intervention group. Fig. 6 . The relationship between the changes in polyphenol intake and the changes in body mass index among the sub jects in the intervention group. Fig. 7 . The relationship between the changes in body mass index and the changes in fasting serum glucose among the subjects in the intervention group. Fig. 8 . The relationship between the changes in body mass index and the changes in fasting serum insulin levels among the subjects in the intervention group.
insulin level, respectively, among the subjects in the intervention group. Mean changes (standard errors) associated with a one-Unit increase of BMI (kg/m2) were 20.61 (6.78), p=0.005 for fasting serum glucose (mg/mL) and 2.54 (0.78), p=0.003 for fasting serum insulin. There were positive correlations of the chan ge in BMI with the changes in blood glucose levell and insulin level.
DISCUSSION
Few studies have analyzed the relationship between the level of consumption of green tea polyphenols and physical biomarkers by measuring the precise amount of intake of green tea polyphenols (catechins). In this study, we asked each subject to rate the strength of green tea that he/she usually drank by choosing from three concentrations of green tea, to ensure higher pre cision in our calculation of the daily level of polyphenol intake. Furthermore, we asked the subjects the size of the teacups that they usually used, and attempted to estimate the level of polyphenol intake more precisely.
The mean baseline BMI was 25.5 in the intervention group and 25.9 in the control group. More than 50% of the subjects in each group were overweight. Further more, the mean systolic blood pressure among all sub jects was at the upper limit of normal, and the mean diastolic blood pressure was at the upper limit of normal or hypertensive. The mean blood glucose level and mean Hb Ale level were also in the range of values for borderline diabetic or diabetic patients. The HOMA index (30) , which is a marker of insulin resistance, was >3.0 in both groups, indicating that most of the sub jects had insulin resistance (33) (34) (35) (36) .
In this study, we administered a supplement of green tea polyphenols for 2 mo to the subjects in the interven tion group. Mean body weight, BMI, blood glucose level, Hb Ale level, insulin level or HOMA index in the inter vention group at 2 mo did not differ significantly from those in the control group because of their similar reduction. Therefore, the expected beneficial effects of consumption of green tea extract/powder were not observed.
The reductions in cardiovascular parameters ob served in both the intervention and control groups may suggest that the subjects in the control group became more sensitive about improving their health in daily life. Another reason for the lack of significant differences between the two groups may be the lack of restrictions on drinking green tea in the control group.
The hs-CRP level tended to increase in the interven tion group 2 mo after green tea supplementation and decreased in the control group, and the intervention group tended to have a higher mean hs-CRP level than the control group. However, the observed difference was interpreted as incidental because there was no signifi cant correlation between the level of polyphenol intake and the hs-CRP level in either group.
Next, by analyzing the relationship between the level of polyphenol intake and biochemical markers among all of the subjects, we found that there tended to be a positive correlation between the level of polyphenol ininninntake and the insulin level.
It has been reported in animal experiments that green tea polyphenols increase insulin activity (37); however, no similar study has been conducted in humans. If an increase in insulin activity does in fact occur in humans, we would expect that consumption of green tea polyphenols would lower the blood insulin concentration and HOMA index. However, the results of this study did not support this hypothesis.
The change in BMI was correlated with the change in blood glucose level among the subjects in the interven tion group. However, we were unable to reach the con clusion that long-term drinking of green tea reduces body weight and thus improves the blood glucose level. Tsuchida et al. (15) studied persons with an average BMI of 24-30kg/m2 who were given a daily dose of 588mg tea catechins and reported that the average body weight of the intervention group (n=39) was 0.54kg less after 4wk and 1.69kg less after 12wk compared with the the control group (n=41).
In conclusion, in this randomized controlled trial, we found that a 544mg/d supplemental intake of green tea polyphenols for 2 mo did not significantly improve the blood glucose level, Hb A1c level, insulin resistance nor the hs-CRP level among diabetic and borderline dia betic patients. The positive correlation between the level of polyphenol intake and insulin level warrants further studies on the effect of green tea on insulin resistance.
